OUI Therapeutics Inc.
New Haven, CT
- UEI
- U4K6RELD5F16
- CAGE
- 850C8
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 513210 Software Publishers Primary
- SAM.gov registration date
- Physical address
- 4 Science Park, New Haven, CT 06511, USA
- Website
- ouitherapeutics.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development and evaluation of a novel digital therapeutic for adults with post-traumatic stress disorder - abstract… | National Institute of Mental Health | $3,099,056 | |
| A self-guided mobile intervention for adults with binge eating and obesity - abstract obesity and comorbid binge… | National Institute of Mental Health | $1,125,819 | |
| A digital psychoeducational social network intervention for suicidal adolescents - abstract suicide is the second… | National Institute of Mental Health | $1,113,118 | |
| An efficacy trial of mobile technology for reducing and preventing adolescent suicide - abstract suicide is a leading… | National Institute of Mental Health | $6,393,680 | |
| Mobile technology for reducing and preventing adolescent suicide - abstract suicide is a top two cause of death in the… | National Institute of Mental Health | $1,196,952 |
About OUI Therapeutics Inc.
OUI Therapeutics Inc. is a for-profit corporate entity based in New Haven, Connecticut, registered in SAM.gov since 2018, that specializes in developing digital therapeutic mobile applications targeting mental health conditions. The company focuses on creating innovative digital interventions for complex mental health challenges, with a particular emphasis on developing technology-based solutions for conditions like post-traumatic stress disorder (PTSD), suicide prevention, binge eating, and obesity. Through its technological approach, OUI Therapeutics aims to provide accessible, scalable mental health interventions that can overcome traditional barriers to treatment such as cost, time constraints, clinician availability, and perceived stigma.
The company has consistently secured federal grant awards from the National Institute of Mental Health (NIMH) to develop and evaluate digital therapeutic applications addressing critical mental health needs. Its primary grant-funded projects include OTX-601 for PTSD treatment, OTX-401 for binge eating and obesity intervention, EYST for suicide prevention among adolescents, and AVIVA, a digital therapeutic targeting suicide prevention for adults and youth. These projects typically follow a phased approach, beginning with initial development and feasibility testing in Phase I, and progressing to larger randomized controlled trials in Phase II. Each project aims to create mobile app-based interventions that can be broadly implemented to enhance mental health treatment accessibility, with a focus on developing scalable, evidence-based digital solutions that can potentially reduce healthcare costs and improve patient outcomes across various mental health domains.
Quick answers
What is OUI Therapeutics Inc.'s UEI?
OUI Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is U4K6RELD5F16.
What is OUI Therapeutics Inc.'s CAGE code?
OUI Therapeutics Inc.'s CAGE code is 850C8.
What is OUI Therapeutics Inc.'s primary NAICS code?
OUI Therapeutics Inc.'s primary NAICS code is 513210 (Software Publishers).
Where is OUI Therapeutics Inc. located?
OUI Therapeutics Inc.'s physical address in SAM.gov is 4 Science Park, New Haven, CT 06511, USA.
Is OUI Therapeutics Inc. registered in SAM.gov?
Yes. OUI Therapeutics Inc.'s SAM.gov registration is active through December 2, 2026.
What is OUI Therapeutics Inc.'s most recent federal award?
OUI Therapeutics Inc.'s most recent federal grant award is Development and evaluation of a novel digital therapeutic for adults with post-traumatic stress disorder - abstract… (R44MH136888), from National Institute of Mental Health, on June 5, 2024.
On GovTribe
See OUI Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors